These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 36937018)

  • 1. Immunogenicity and efficacy of serogroup A and D bacterins against
    Guan LJ; Yang JQ; Xu QY; Feng YF; Zhang XC; Tang B; Zhao ZQ
    Front Vet Sci; 2023; 10():1132536. PubMed ID: 36937018
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunogens of Pasteurella.
    Confer AW
    Vet Microbiol; 1993 Nov; 37(3-4):353-68. PubMed ID: 8116191
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immune Protective Efficacy of China's Traditional Inactivated and Attenuated Vaccines against the Prevalent Strains of
    Guan LJ; Song JJ; Xue Y; Ai X; Liu ZJ; Si LF; Li MY; Zhao ZQ
    Vaccines (Basel); 2021 Oct; 9(10):. PubMed ID: 34696263
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recombinant-attenuated Salmonella enterica serovar Choleraesuis vector expressing the PlpE protein of Pasteurella multocida protects mice from lethal challenge.
    Zhou G; Tian J; Tian Y; Ma Q; Li Q; Wang S; Shi H
    BMC Vet Res; 2023 Aug; 19(1):128. PubMed ID: 37598169
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Occurrence of
    Liu H; Zhao Z; Xi X; Xue Q; Long T; Xue Y
    Ir Vet J; 2017; 70():2. PubMed ID: 28078081
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protective efficacy afforded by live Pasteurella multocida vaccines in chickens is independent of lipopolysaccharide outer core structure.
    Harper M; John M; Edmunds M; Wright A; Ford M; Turni C; Blackall PJ; Cox A; Adler B; Boyce JD
    Vaccine; 2016 Mar; 34(14):1696-703. PubMed ID: 26892738
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Importance of strain selection in the generation of heterologous immunity to Glaesserella (Haemophilus) parasuis.
    Hau SJ; Eberle KC; Brockmeier SL
    Vet Immunol Immunopathol; 2021 Apr; 234():110205. PubMed ID: 33636545
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pasteurella multocida inactivated with ferric chloride and adjuvanted with bacterial DNA is a potent and efficacious vaccine in Balb/c mice.
    Homayoon M; Tahamtan Y; Kargar M; Hosseini SMH; Akhavan Sepahy A
    J Med Microbiol; 2018 Sep; 67(9):1383-1390. PubMed ID: 30016232
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fowl cholera: induction of cross-protection in turkeys with bacterins prepared from host-passaged Pasteurella multocida.
    Rebers PA; Heddleston KL
    Avian Dis; 1977; 21(1):50-6. PubMed ID: 843303
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of Pasteurella multocida isolated from dead rabbits with respiratory disease in Fujian, China.
    Wang J; Sang L; Sun S; Chen Y; Chen D; Xie X
    BMC Vet Res; 2019 Dec; 15(1):438. PubMed ID: 31801544
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Capsular serotyping of Pasteurella multocida from various animal hosts - a comparison of phenotypic and genotypic methods.
    Arumugam ND; Ajam N; Blackall PJ; Asiah NM; Ramlan M; Maria J; Yuslan S; Thong KL
    Trop Biomed; 2011 Apr; 28(1):55-63. PubMed ID: 21602769
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cross-protection of recombinant Pasteurella multocida toxin proteins against atrophic rhinitis in mice.
    Wu MC; Lo YT; Wu HC; Wang HY; Chu CY
    Res Vet Sci; 2021 Jul; 137():138-143. PubMed ID: 33975192
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Conformational comparisons of Pasteurella multocida types B and E and structurally related capsular polysaccharides.
    Richardson NI; Ravenscroft N; Kuttel MM
    Glycobiology; 2023 Oct; 33(9):745-754. PubMed ID: 37334939
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protective effects of inactivated Pasteurella vaccines in specific pathogen free rabbits.
    Okerman L; Spanoghe L
    Comp Immunol Microbiol Infect Dis; 1981; 4(2):223-8. PubMed ID: 7348211
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A capsule/lipopolysaccharide/MLST genotype D/L6/ST11 of Pasteurella multocida is likely to be strongly associated with swine respiratory disease in China.
    Peng Z; Wang H; Liang W; Chen Y; Tang X; Chen H; Wu B
    Arch Microbiol; 2018 Jan; 200(1):107-118. PubMed ID: 28825122
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recombinant transferrin binding protein A (rTbpA) fragments of Pasteurella multocida serogroup B:2 provide variable protection following homologous challenge in mouse model.
    Shivachandra SB; Yogisharadhya R; Kumar A; Mohanty NN; Nagaleekar VK
    Res Vet Sci; 2015 Feb; 98():1-6. PubMed ID: 25544697
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dendritic cell targeting peptide plus Salmonella FliCd flagellin fused outer membrane protein H (OmpH) demonstrated increased efficacy against infections caused by different Pasteurella multocida serogroups in mouse models.
    Wang Z; Wang M; Wang F; Luo Y; Liu H; Zhu Z; Huang X; Hua L; Chen H; Wu B; Peng Z
    Vaccine; 2024 Apr; 42(12):3075-3083. PubMed ID: 38584060
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cross-protection conferred by immunization with an rOmpH-based intranasal fowl cholera vaccine.
    Varinrak T; Poolperm P; Sawada T; Sthitmatee N
    Avian Pathol; 2017 Oct; 46(5):515-525. PubMed ID: 28421815
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Candidate vaccine antigens and genes in Pasteurella multocida.
    Adler B; Bulach D; Chung J; Doughty S; Hunt M; Rajakumar K; Serrano M; van Zanden A; Zhang Y; Ruffolo C
    J Biotechnol; 1999 Aug; 73(2-3):83-90. PubMed ID: 10486918
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cross-protection studies with Pasteurella multocida bacterins prepared from bacteria propagated in iron-depleted medium.
    Glisson JR; Contreras MD; Cheng IH; Wang C
    Avian Dis; 1993; 37(4):1074-9. PubMed ID: 8141736
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.